Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Roche's Avastin approved in E.U. for first-line treatment of NSCLC patients

Aug. 27, 2007

Thallion completes phase I/II trial of ECO-4601 for advanced cancer

Aug. 27, 2007

Fast track designation for Marqibo in treatment of relapsed ALL

Aug. 23, 2007

Genta begins phase III trial of Genasense for advanced melanoma

Aug. 23, 2007

Abraxis BioScience and TRSI enter epothilone licensing agreement for cancer

Aug. 23, 2007

FDA grants orphan drug designation to Pharmion and MethylGene's MGCD-0103

Aug. 23, 2007

Positive results for Antisoma's ASA-404 in phase II lung cancer trial

Aug. 23, 2007

Phenoxodiol may reduce cisplatin-induced neuropathy

Aug. 22, 2007

FDA approvable letter issued for Indevus' drug candidate Valstar

Aug. 22, 2007

Cell Therapeutics to acquire Zevalin from Biogen Idec for U.S. sales and marketing

Aug. 22, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...